SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ImmunityBio converts from Immunomedics
An SI Board Since February 2023
Posts SubjectMarks Bans Symbol
1216 46 0 IBRX
Emcee:  TinfoilHat Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1141Well, committing scarce resources to chase a long Covid treatment hasn’t seemed jargonweary6August 19
1140We agree with your analysis, and share your frustrations. We are hanging our habobbseytwins20012August 18
1139I am all for having a positive outlook on things in general, so I appreciate youluckydog883August 18
1138I have to agree with Galt, and while that doesn't mean I fundamentally disagFitzhughlaw6August 15
1137PSS may be able to keep cash flow positive with his checking account (one of theOlecranon2August 15
1136Agree to disagree. I see a number of changes in PSS, having followed him for a galt4August 15
1135PSS is the multi-billionaire here in the IBRX story. Not only is he a brilliantbobbseytwins20012August 15
1134If PSS wanted to send a loud and clear message to the marketplace he would avoidgalt6August 15
1133The risk is dilution. With only limited current approvals for Anktiva, there is Olecranon2August 15
1132Come on guys! These people are trying to run a small biotech company, and they bobbseytwins20016August 14
1131I do agree that the Keystone Cops crew now at the FDA is a serious problem for ajargonweary2August 14
1130Absent some truly meteoric news or change in status, I remain pessimistic about Olecranon-August 14
1129The lack of follow through today is as disappointing as it is unsurprisingjargonweary1August 14
1128From Xai x.comEnd2War-August 14
1127New long covid trials. One already recruiting. clinicaltrials.gov clinicaltrimannamal-August 14
1126D. Boral Capital Maintains Buy on ImmunityBio, Maintains $24 Price Target BENZINluckydog882August 14
1125The Quilt-106 trial (NCT06334991, N=10) in SA does not include Anktiva. In the QHuggenberg2August 14
1124My question to Chat-GPT5 and its response: Question: Review this PR from IBEnd2War3August 13
1123Nice volume. Gotta work on that 77M short position …erippetoe1August 13
1122I could be wrong but I don’t think this trial involves anktiva fwiw. At least Ierippetoe-August 13
1121I had also noted this a few days ago, and while it’s yet more validation of AnktFitzhughlaw4August 13
1120ImmunityBio Reports Complete Responses in Non-Hodgkin Waldenstrom Lymphoma Patieerippetoe5August 13
1119I find it significant that we're attending Bio-Europe in November. informacmannamal-August 13
1118Oopsmannamal-August 13
1117clinicaltrials.govmannamal-August 6
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News